Vis enkel innførsel

dc.contributor.advisorKnutsen, Erik
dc.contributor.authorBerge, Anne Kristin McLaren
dc.date.accessioned2025-08-25T12:05:39Z
dc.date.available2025-08-25T12:05:39Z
dc.date.issued2025-09-26
dc.description.abstractTRIM proteins are E3 ubiquitin ligases, meaning that they modify other substrate proteins with ubiquitin, either tagging them for destruction or influencing their function. We have focused on three TRIM proteins, TRIM32, TRIM45, and TRIM27. Using in silico and in vitro methods we have further elucidated the importance of TRIM proteins in tumorigenesis and autophagy. In our study we found TRIM32 to be associated with head and neck cancer and patients with high expression of TRIM32 having worse prognosis. TRIM32 might worsen the prognosis by increasing glycolysis through MYC signaling, that could increase the expression of glycolytic proteins, including HK2 and LDHA. This may further promote tumor growth, metastasis, and proliferation. We also identified TRIM45 as an estrogen receptor (ER) associated gene, and that higher TRIM45 expression improved the prognosis of ER-positive breast cancer patients. The glycoprotein STC2 was found to be upregulated in response to elevated TRIM45 expression and contributed to better prognosis. TRIM45 might be an estrogen responsive gene, but the exact mechanism behind TRIM45 regulation and its cooperation with STC2 to improve prognosis needs further research. Lastly, in our project, TRIM27 was observed to induce clustering of mitochondria by interacting with the selective autophagy receptor SQSTM1/p62. Additionally, the kinase TBK1 was involved in the clustering process. TRIM27 is suspected to act as a scaffold for the activation of TBK1 and SQSTM1/p62 to promote clustering of mitochondria and mitophagy.en_US
dc.description.doctoraltypeph.d.en_US
dc.description.popularabstractCancer is a disease, defined by uncontrollably cell growth and can potentially spread to other parts of the body. The cancer cells, or the body’s reaction to cancer, can send out messages that can help us understand the behavior of the cancer. Therefore, research today is actively trying to find these messages and figure out how to use them to improve cancer treatment. These messages include modifying TRIM proteins, that can tag other proteins for destruction or influence their function. Using computational methods and lab experiments, we have identified that these modifying proteins have an impact on the survival of cancer patients. These proteins can also take a part in the clean-up of mitochondria, often called the powerhouse of the cell, which can have an effect on cancer. Understanding the role of these modifying proteins in cancer can lead to the development of new treatments, enhancing patient survival and overall well-being.en_US
dc.identifier.isbn978-82-350-0040-8
dc.identifier.urihttps://hdl.handle.net/10037/38020
dc.language.isoengen_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.relation.haspartPaper I: Berge, A.K.M., Sanchez, O.R.E., von Hofsten, S., Figenschaug, S., Schwienbacher, R., Five, M-B., Hegge, B., Sellæg, K., Magnussen, S.N., Sjøttem, E. & Knutsen., E. (2025). TRIM32 is associated with MYC signaling and poor prognosis in Head and Neck Squamous Cell Carcinoma. (Manuscript). <p> <p>Paper II: Berge, A.K.M., Sanchez, O.R.E., Newmand, N., Figenschau, S., Albers, C., Hedberg, A., von Hofsten, S., Sjøttem, E., Kuijjer, M.L. & Knutsen, E., (2025). TRIM45 is a Positive Prognostic Marker in ER-Positive Breast Cancer. (Manuscript).<p> <p>Paper III: Garcia-Garcia, J., Berge, A.K.M., Overa, K.S., Larsen, K.B., Bhajabal, Z., Brech, A., Abudu, Y.P., Lamark, T., Johansen, T. & Sjøttem, E. (2022). TRIM27 is an autophagy substrate facilitating mitochondria clustering and mitophagy via phosphorylated TBK1. <i>The FEBS Journal, 290</i>(4), 1096 – 1116. Also available in Munin: <a href=https://hdl.handle.net/10037/28048>https://hdl.handle.net/10037/28048</a>.en_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2025 The Author(s)
dc.subjectTRIM Proteinsen_US
dc.subjectAutophagyen_US
dc.subjectBreast Canceren_US
dc.subjectHead and neck squamous cell carcinomaen_US
dc.titlePathological mechanisms of the ubiquitin E3 ligases TRIM27, TRIM32 and TRIM45 in cancer and autophagyen_US
dc.typeDoctoral thesisen_US
dc.typeDoktorgradsavhandlingen_US


Tilhørende fil(er)

Thumbnail
Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel